← Holders
Silverarc Capital Management, LLC
What Silverarc Capital Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1816307 · Filed Nov 12, 2026
- Positions
- 70
- Reported value
- $854.4M
- Opened
- 18
- Closed
- 21
- Other managers included
- 1
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$741.6M82 positions
- Dec 31, 2025$720.1M68 positions
- Mar 31, 2026$979.8M73 positions
- Jun 30, 2026$962.2M73 positions
- Sep 30, 2026$854.4M70 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
KODKodiak Sciences Inc. | 750.2K | +37.3% | $71.1M | 8.3% |
CELCCelcuity Inc. | 803.2K | +60.3% | $63.9M | 7.5% |
COGTCogent Biosciences, Inc. | 1.6M | +23.0% | $50.4M | 5.9% |
URGNUroGen Pharma Ltd. | 1.1M | −11.8% | $46.7M | 5.5% |
IMNMImmunome Inc. | 2.1M | +3.8% | $45M | 5.3% |
GLUEMonte Rosa Therapeutics, Inc. | 3.1M | +180.9% | $37.1M | 4.3% |
SGMTSagimet Biosciences Inc. | 3.7M | +28.0% | $37M | 4.3% |
ASNDAscendis Pharma A/S | 152.2K | −26.2% | $34.7M | 4.1% |
RYTMRhythm Pharmaceuticals, Inc. | 348.3K | +11.8% | $33.2M | 3.9% |
BIIBBiogen Inc. | 112.8K | +134.5% | $25.5M | 3% |
IMVTImmunovant, Inc. | 624.1K | +0.8% | $21.1M | 2.5% |
DNTHDianthus Therapeutics, Inc. | 236.6K | −39.3% | $20.8M | 2.4% |
ORKAOruka Therapeutics, Inc. | 247.9K | −29.7% | $20.6M | 2.4% |
ERASErasca, Inc. | 1.3M | +5.3% | $19.5M | 2.3% |
ABVXAbivax S.A. | 175.7K | +3.6% | $17.4M | 2% |
CLDXCelldex Therapeutics, Inc. | 487.6K | New | $15.8M | 1.8% |
OVIDOvid Therapeutics Inc. | 6M | +91.9% | $14.8M | 1.7% |
SYRESpyre Therapeutics, Inc. | 151.2K | +152.1% | $13.5M | 1.6% |
DFTXDefinium Therapeutics, Inc. | 345.9K | −13.5% | $13.2M | 1.5% |
HLXCHelix Acquisition Corp. III | 1.2M | +2.6% | $12.8M | 1.5% |
ALKSAlkermes plc. | 300.4K | +164.7% | $12.2M | 1.4% |
CELLDEX THERAPEUTICS INC NEWCALLCall option | 370.7K | New | $12M | 1.4% |
CCCCC4 Therapeutics, Inc. | 3.5M | +13.9% | $11.5M | 1.3% |
AVLNAvalyn Pharma Inc. | 378.4K | +14.5% | $10.8M | 1.3% |
ORIC PHARMACEUTICALS INCCALLCall option | 702.4K | +2.9% | $9.5M | 1.1% |
CERSCerus Corp | 4M | +13.8% | $9.4M | 1.1% |
ALXOALX Oncology Holdings Inc | 6.6M | +14.3% | $9.1M | 1.1% |
ZBIOZenas BioPharma, Inc. | 334.1K | −34.5% | $9M | 1.1% |
CMPSCOMPASS Pathways plc | 717.4K | +42.5% | $8.9M | 1% |
RNAQURainier Acquisition Corp | 853.9K | New | $8.7M | 1% |
CGENCompugen Ltd | 3.6M | +12.6% | $8.5M | 1% |
SVRASavara Inc | 1.5M | +12.1% | $7.8M | 0.9% |
PCVXVaxcyte, Inc. | 125.1K | −13.7% | $7.1M | 0.8% |
YARWYarrow Bioscience, Inc. | 301.9K | New | $6.8M | 0.8% |
IBIOiBio, Inc. | 5.4M | +52.2% | $6.3M | 0.7% |
ARCTArcturus Therapeutics Holdings Inc. | 459.9K | New | $6.3M | 0.7% |
MONTE ROSA THERAPEUTICS INCCALLCall option | 525K | +75.0% | $6.3M | 0.7% |
PRAXPraxis Precision Medicines, Inc. | 19.8K | −69.9% | $5.8M | 0.7% |
KNSAKiniksa Pharmaceuticals International, plc | 75.7K | New | $5.6M | 0.7% |
ELVNEnliven Therapeutics, Inc. | 121.5K | −75.2% | $5.6M | 0.7% |
SLDBSolid Biosciences Inc. | 760.3K | +13.7% | $5.5M | 0.6% |
EVMNEvommune, Inc. | 594K | New | $4.9M | 0.6% |
SNDXSyndax Pharmaceuticals Inc | 247.4K | −79.6% | $4.7M | 0.5% |
BNTCBenitec Biopharma Inc. | 443.1K | −34.8% | $4.4M | 0.5% |
RACCResearch Alliance Corp III | 404.7K | +12.4% | $4.4M | 0.5% |
BLSMBlossomHill Therapeutics, Inc. | 202.1K | New | $3.8M | 0.4% |
FTHFaeth Therapeutics, Inc. | 124.1K | New | $3.7M | 0.4% |
ABEOAbeona Therapeutics Inc. | 693.4K | +13.6% | $3.6M | 0.4% |
RACDResearch Alliance Corp IV | 302K | New | $3.5M | 0.4% |
ANLAdlai Nortye Group Ltd. | 216.6K | New | $3.5M | 0.4% |
PALIPalisade Bio, Inc. | 2.3M | New | $3.2M | 0.4% |
IRONDisc Medicine, Inc. | 47.3K | −42.9% | $3.1M | 0.4% |
ABSCI CORPORATIONPUTPut option | 254.7K | +61.6% | $2.7M | 0.3% |
TELATELA Bio, Inc. | 2.1M | ±0% | $2.5M | 0.3% |
ZVRAZevra Therapeutics, Inc. | 200.3K | New | $2.2M | 0.3% |
ORICOric Pharmaceuticals, Inc. | 160.6K | −78.3% | $2.2M | 0.3% |
CTNMContineum Therapeutics, Inc. | 159K | −46.3% | $2.1M | 0.2% |
MRNAModerna, Inc. | 10K | New | $1.9M | 0.2% |
ELUTElutia Inc. | 2.2M | ±0% | $1.7M | 0.2% |
FULCRUM THERAPEUTICS INCCALLCall option | 391.9K | ±0% | $1.5M | 0.2% |
QUREuniQure N.V. | 56.7K | −46.0% | $1.4M | 0.2% |
ACHVAchieve Life Sciences, Inc. | 159K | −30.0% | $1.3M | 0.2% |
ACRSAclaris Therapeutics, Inc. | 238.5K | −87.7% | $1.3M | 0.1% |
RAPPRapport Therapeutics, Inc. | 35.5K | New | $1.2M | 0.1% |
ZURA BIO LTDCALLCall option | 242.2K | New | $1M | 0.1% |
CAMPCamp4 Therapeutics Corp | 183.1K | −72.0% | $739.6K | 0.1% |
ANNEXON INCCALLCall option | 131.5K | New | $556.2K | 0.1% |
ZURAZura Bio Ltd | 100K | New | $416K | 0.1% |
CLRBCellectar Biosciences, Inc. | 151.1K | −53.0% | $278.1K | 0.1% |
ADGMAdagio Medical Holdings, Inc. | 170.5K | −24.0% | $26.1K | 0.1% |